Showing results (491-500 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|August 15, 2002
Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work statusL Shi, M A Namjoshi, F Zhang, et al.International Clinical Psychopharmacology|August 15, 2002
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range studyH Lôo, A Hale, H D'haenenInternational Clinical Psychopharmacology|August 15, 2002
Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophreniaK Alptekin, B B KivircikInternational Clinical Psychopharmacology|August 15, 2002
A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) studyM Arato, R O'Connor, H Y Meltzer, et al.International Clinical Psychopharmacology|November 1, 2002
Dysphoric mania induced by high-dose mirtazapine: a case for 'norepinephrine syndrome'?N H Bhanji, H C Margolese, M Saint-Laurent, et al.International Clinical Psychopharmacology|September 1, 1999
Effects of tiapride on electroencephalograms and cognitive functions in the elderlyA Patat, H Alberini, D Bonhomme, et al.International Clinical Psychopharmacology|September 1, 1999
Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophreniaS Ulrich, S Neuhof, V Braun, et al.International Clinical Psychopharmacology|September 1, 1999
Prevalence of headache syndromes in panic disorderD Marazziti, C Toni, S Pedri, et al.International Clinical Psychopharmacology|September 1, 1999
The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunctionN Koutouvidis, M Pratikakis, A FotiadouPageof 212